Vivani Medical, Inc. financial data

Symbol
VANI on Nasdaq, VANIW on OTC
Industry
Electromedical & Electrotherapeutic Apparatus
Location
1350 S. Loop Road, Alameda, California
State of incorporation
California
Fiscal year end
December 31
Former names
SECOND SIGHT MEDICAL PRODUCTS INC (to 8/18/2022), SECOUND SIGHT MEDICAL PRODUCTS INC (to 10/10/2003)
Latest financial report
Q1 2024 - May 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 460 % -51.9%
Debt-to-equity 96.6 % +487%
Return On Assets -47.8 % -60.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 55M shares +8.36%
Common Stock, Shares, Outstanding 55K shares +8.25%
Entity Public Float 38.9M USD
Common Stock, Value, Issued 109M USD -68.7%
Weighted Average Number of Shares Outstanding, Basic 52.2M shares +2.85%
Weighted Average Number of Shares Outstanding, Diluted 50.8K shares +32.1%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 16.7M USD +8.38%
General and Administrative Expense 9.85M USD +16%
Operating Income (Loss) -26.6M USD -11.1%
Net Income (Loss) Attributable to Parent -25.4M USD -55.8%
Earnings Per Share, Basic 0.12 USD/shares 0%
Earnings Per Share, Diluted -0.13 USD/shares -425%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 29.6M USD -22.1%
Assets, Current 31.5M USD -22.6%
Property, Plant and Equipment, Net 1.69M USD +52%
Operating Lease, Right-of-Use Asset 19.2M USD +1574%
Other Assets, Noncurrent 1.34M USD -2.05%
Assets 53.8M USD +20.7%
Accounts Payable, Current 570K USD -23.6%
Employee-related Liabilities, Current 506K USD +21.9%
Accrued Liabilities, Current 1.95M USD -7.62%
Contract with Customer, Liability, Current 335K USD 0%
Liabilities, Current 6.14M USD +4.69%
Operating Lease, Liability, Noncurrent 18.9M USD +5327%
Liabilities 25.1M USD +304%
Accumulated Other Comprehensive Income (Loss), Net of Tax 88K USD +100%
Retained Earnings (Accumulated Deficit) -104M USD -32.1%
Stockholders' Equity Attributable to Parent 28.7M USD -25.2%
Liabilities and Equity 53.8M USD +20.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.51M USD +35.2%
Net Cash Provided by (Used in) Financing Activities 13.7M USD
Net Cash Provided by (Used in) Investing Activities -182K USD -392%
Common Stock, Shares Authorized 300K shares 0%
Common Stock, Shares, Issued 55K shares +8.25%
Common Stock, Par or Stated Value Per Share 4.14 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.99M USD
Deferred Tax Assets, Valuation Allowance 60.9M USD +11%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 63M USD +11.4%
Payments to Acquire Property, Plant, and Equipment 182K USD +392%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -25.3M USD -56%
Property, Plant and Equipment, Gross 4.23M USD +16.6%
Operating Lease, Liability, Current 1.43M USD +57.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Deferred Tax Assets, Operating Loss Carryforwards 184M USD
Unrecognized Tax Benefits 1.69M USD
Operating Lease, Payments 30M USD
Additional Paid in Capital 133M USD +1489%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 99K USD -8.33%
Share-based Payment Arrangement, Expense 1.85M USD +39.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares